Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELY-ABLE: Long-term dabigatran extension in atrial fibrillation
NCT00808067Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2008
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 35
01
Overview
A Phase 3 trial of dabigatran in Atrial fibrillation (AFib), sponsored by Boehringer Ingelheim. Started Nov 2008; status: completed.
02
Drugs
dabigatran
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00808067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00808067.